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Type 1 diabetes is a T-cell–mediated chronic disease characterized by the autoimmune destruction of pancreatic
insulin-producing b cells and complete insulin deficiency. It is the result of a complex interrelation of genetic and
environmental factors, most of which have yet to be identified. Simultaneous identification of these genetic factors,
through use of unphased genotype data, has received increasing attention in the past few years. Several approaches
have been described, such as the modified transmission/disequilibrium test procedure, the conditional extended
transmission/disequilibrium test, and the stepwise logistic-regression procedure. These approaches are limited either
by being restricted to family data or by ignoring so-called “haplotype interactions” between alleles. To overcome
this limit, the present study provides a general method to identify, on the basis of unphased genotype data, the
haplotype blocks that interact to define the risk for a complex disease. The principle underpinning the proposal is
minimal entropy. The performance of our procedure is illustrated for both simulated and real data. In particular,
for a set of Dutch type 1 diabetes data, our procedure suggests some novel evidence of the interactions between
and within haplotype blocks that are across chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 11, 12, 15, 16, 17, 19, and 21.
The results demonstrate that, by considering interactions between potential disease haplotype blocks, we may
succeed in identifying disease-predisposing genetic variants that might otherwise have remained undetected.
Introduction
Insulin-dependent diabetes mellitus (IDDM [MIM
222100]), or type 1 diabetes, is a common chronic dis-
ease characterized by autoimmune destruction of pan-
creatic b cells and complete insulin deficiency (Cordell
and Todd 1995; Schranz and Lernmark 1998; Friday et
al. 1999). The importance of some genetic factors for
the etiology of type 1 diabetes, such as human leukocyte
antigen (HLA), has been established unequivocally, al-
though their precise mechanism has not been identified.
Evidence that the immune system and apoptosis play a
role is accumulating. Both processes contribute to the
deterioration of b cells in the islets of Langerhans in the
pancreas. Despite this information, no definite genetic
cause can be determined in most patients, not even in
the presence of a positive family history. In this article,
we present a method, for testing the influence of hap-
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lotype interactions on developing disease, that can be
used when unphased genotypes are available for a num-
ber of cases and controls, and we apply this method to
genotype data of patients with type 1 diabetes and of
healthy controls. Here, as in the article by Bugawan et
al. (2003), “haplotype interaction” is defined as the sta-
tistical dependence between alleles at different loci.
The increasing availability of polymorphic markers
such as SNPs, automated genotyping technology, and
large collections of family-based (or case-control–based)
data have enabled the design of genomewide screens for
several populations. Such screens have led to the loca-
tion of susceptibility loci for type 1 diabetes in various
chromosomal regions, suggesting that type 1 diabetes
is a multigenic disorder, in the sense that onset of the
disease requires the simultaneous presence of a subset
of susceptibility genes. Most recent research efforts have
concentrated on HLA genes (see Cox et al. [2001] and
Pugliese [2001] for reviews). The importance of the
HLA class II haplotypes was shown by Noble et al.
(2002) in families with at least two children with in-
sulin-dependent diabetes.
Once a disease-predisposing region has been localized,
a number of potentially causative genetic variants may
exist in the region, including a large number of SNPs.
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Whereas, for monogenic diseases, one base change in the
coding region of a gene very often is sufficient to cause
the disease, for multigenic diseases the effect of any single
genetic variant on the risk of the disease may be small,
which makes identification of these variants difficult
(Drysdale et al. 2000). Furthermore, the following ques-
tions related to identification of the multiple risk variants
arise. First, it is not clear which combination of variants
has a causative role in the disease. Second, it remains
unknown whether susceptibility for the disease arises be-
cause of the effects of these variants acting independently
or because of some important interactions between the
variants.
These questions have received increasing attention re-
cently (see, for example, Valdes and Thomson 1997; Cox
et al. 1999; Dassen et al. 2001; Cordell and Clayton
2002; Bugawan et al. 2003). Cordell and Clayton (2002)
proposed a simple but powerful stepwise logistic-regres-
sion procedure that allows for testing the dominance ef-
fects of different combinations of polymorphisms, as well
as genotype interactions in the analysis of case-control
data. In particular, they measured genotype interactions
in terms of penetrance for developing disease. However,
haplotype interactions, since the underlying haplotype
pairs of unphased genotypes may have different disease
risks, so that there are disease-predisposing interactions,
cannot be dealt with in their approach. To illustrate this,
for the moment, we consider two diallelic variants of
interest in a region: variant 1, with one of the unphased
genotypes aa, AA, and aA; and variant 2, with one of
the unphased genotypes bb, BB, and bB. There are nine
possible combinations (also called “genotypes”) observed
at the two variants: aa/bb, aa/bB, aa/BB, AA/bb, AA/bB,
AA/BB, aA/bb, aA/bB, and aA/BB, where, for example,
aA/bb means that the alleles in variants 1 and 2 are
and , respectively. All of these genotypes except{a,A} {b,b}
for aA/bB can be uniquely decomposed into a pair of
haplotypes. For aA/bB, there are two compatible possible
haplotype pairs, and . The pairing(a,b)/(A,B) (a,B)/(A,b)
described here indicates that allele a is coupled with allele
b or allele a is coupled with allele B.
It is only when these two haplotype pairs have dif-
ferent disease risks that there may be potential disease-
predisposing interactions between a and b or a and B.
As pointed out by a reviewer, even when the haplotype
pairs do have different disease risks, it does not nec-
essarily mean that the alleles interact in anything other
than a statistical sense, since this phenomenon could
occur if alleles a and b, say, were in linkage disequilib-
rium with (and, thus, marking a haplotype containing)
another predisposing variant not included in the anal-
ysis. Note that the stepwise logistic-regression proce-
dure takes genotypes as explanatory variables and,
therefore, the possible difference between the effects of
the underlying haplotypes on the disease is ignored.
An alternative test is called the “haplotype method”
(Valdes and Thomson 1997), which compares the relative
frequencies of alleles at a secondary locus on haplotypes
that are identical at a primary locus (or loci). The problem
with the haplotype method is that, often, the haplotypes
are not known. Although one can statistically infer the
haplotypes from unphased genotypes, it is unclear how
to judge the significance of the results from the haplotype
method if we want to take into account the possible
haplotyping errors. Several other approaches have been
described for simultaneous identification of genetic fac-
tors through use of unphased genotype data, such as
the modified transmission/disequilibrium test procedure
(Cucca et al. 2001) and the conditional extended trans-
mission/disequilibrium test (Koeleman et al. 2000). These
approaches are also limited, by being restricted either to
family data or to haplotype data. This and the fact that
there are possible haplotype pairs for a genotype ofm12
m heterozygous sites, which results in a considerable
number of potential haplotype interactions when m is
large, motivated us to develop a special procedure for
testing such interactions. The proposed method is based
on minimal entropy, reflecting the principle that a good
prediction of haplotype interactions should extract a
maximum amount of information from data and, thus,
most parsimoniously explain the underlying haplotype
structure, given unphased genotypes. In general, the com-
putation of the entropy statistic is very intensive. To solve
this problem, we have developed a new Markov chain
Monte Carlo algorithm called the “structure-annealing
algorithm.”
Two types of approaches for the investigation of in-
teraction can be distinguished: those that consider in-
teraction in the sense of linkage disequilibrium between
closely linked loci (Wall and Pritchard 2003) and those
that consider interaction in the sense of effects on dis-
ease risk (Cordell and Todd 1995; Cordell et al. 2001).
In this article, we focus on the linkage disequilibrium
approach while investigating interaction between all
loci and, hence, also between possibly unlinked loci.
For any two haplotype blocks, let us denote by andp1a
the probabilities of occurrence for allele a at blockp2b
1 and for allele b at block 2, respectively. Let be thepab
probability of simultaneous occurrence of a and b. We
are trying to test whether, for all a and b, .p p p pab 1a 2b
We assess the evidence for interactions between and
within (possibly unlinked) haplotype blocks on different
chromosomal regions by using a permutation proce-
dure. Since the strength of a linkage disequilibrium pat-
tern is not, typically, a monotonic function of recom-
bination distance when there exist selective forces that
favor certain haplotypes over others, as might be the
case for type 1 diabetes (Fain and Eisenbarth 2001), we
needed to develop an approach that is independent of
this distance. Naturally, we are mainly interested in
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identification of disease-predisposing interactions by
comparisons between cases and controls. The disease-
predisposing interactions are found in a second stage,
by contrasting the interaction patterns observed for pa-
tients with the interaction patterns observed for healthy
controls. These interactions could facilitate understand-
ing of the pathological mechanisms involved in the dis-
ease, as well as the further identification of some hap-
lotype blocks that provide significant association with
the disease only when their interactions with other
blocks are taken into account.
As an illustration of our method, we present in this
article a reanalysis of a set of genotypes that was ob-
tained from a cohort of 89 Dutch patients with type 1
diabetes and 47 healthy control individuals, with a 65-
polymorphism detection assay originally designed for
unraveling the multigenic cause of atherosclerosis (Das-
sen et al. 2001). Since both diabetes mellitus and ath-
erosclerosis can be regarded as metabolic diseases with
many overlapping biochemical and clinical parameters,
the variants that are susceptible to atherosclerosis may
also be the cause of type 1 diabetes. Dassen et al. (2001)
examined whether certain types of combinations of
SNPs confer susceptibility to type 1 diabetes in the co-
hort by logistic regression and self-learning neural net-
works. They found that a set of four polymorphisms
could predict 79.9% of the cases correctly. However, a
significant number of polymorphisms could not be in-
terpreted by their method. Note that all of these variants
were selected from the pathways of lipid and homo-
cysteine metabolism, regulation of blood pressure and
coagulation, inflammation, cellular adhesion, and ma-
trix integrity. Therefore, we wondered whether the var-
iants that were unexplained in the above-mentioned
study may serve as transitive (or supporting) variants,
in the sense that they interact with some etiological var-
iants within and between these pathways.
Before we applied the proposed procedure to the
above-mentioned Dutch type 1 diabetes data, we eval-
uated the power of our approach by conducting a sim-
ulation study in which four different combinations of
mutation and recombination rates were considered. The
results are presented below. They suggest that a high
accuracy can be achieved if appropriate critical values
for our entropy statistics are selected. Note that, al-
though the coalescent model that we have used for our
simulations has been shown to be very helpful in mod-
eling haplotype populations (Stephens et al. 2001), it is
still not easy to statistically test whether this model fits
real data, such as the Dutch type 1 diabetes data. There-
fore, the thresholds that were obtained from the sim-
ulations were used as a guide to the corresponding pa-
rameters as we applied our method to the data. The
results of our data analysis show some evidence for a
haplotype interaction network that is potentially asso-
ciated with type 1 diabetes and that includes the up
interactions between the haplotype blocks from the
chromosomes pairs (1,4), (1,12), (1,19), (6, 7), and (17,
21), as well as the down interactions between blocks
from the chromosome pairs (2,7), (3,19), (5,7), (6,21),
and (7,11). There are several other less significant pairs.
Here, “up interaction” and “down interaction” mean
that there exists a significant increase or decrease, re-
spectively, in interaction between two blocks for pa-
tients over that for controls. We further found some
disease-predisposing intrablock interactions on chro-
mosomes 1, 6, 7, 8, and 11. Finally, we searched for
loci interactions that may account for these block in-
teractions. As a result, a total of 25 potential disease-
predisposing interactions between loci are predicted,
which indicates 19 gene-gene interactions among 19
candidate genes. Having found four dominant variants
(Dassen et al. 2001), we predicted, from the interaction
network, 19 transitive variants. Our results clearly dem-
onstrate that, by considering interactions between hap-
lotype blocks, we may succeed in identifying disease-




Let denote the observed genotypesTGp (G , … ,G )1 n
for n individuals from a population, where G pi
, is the genotype of individual i at locusT(g , … ,g ) gi1 iL ij
j, and L is the total number of observed loci per indi-
vidual. For simplicity, let take values of 0, 1, or 2 forgij
the cases in which its genetic haplotype at locus j is
homozygous and identical to a prespecified reference,
homozygous but different from the reference, or hetero-
zygous, respectively. In addition, we let if alleleg p 7ij
0 is missing at locus j, if allele 1 is missing, andg p 8ij
if both alleles are missing. A genotype is calledg p 9ij
“ambiguous” if it has at least two heterozygous sites.
Let , where denotes theTHp (H , … ,H ) H p (H ,H )1 n i i1 i2
unobserved haplotype pair of , and , the setG H  Hi i i
of all possible haplotype pairs compatible to . GivenGi
, under the assumption of Hardy-Weinberg equilib-G
rium (Weir 1996, chapter 3), the “haplotype likelihood”
can then be written as
n
L(GFp,H)p p(H )p(H ) , (1) i1 i2
ip1
where denotes the population frequency of the cor-p(7)
responding haplotype, and . Here we as-pp (p , … ,p )1 m0
sume that, overall, there are possible haplotypes com-m0
patible with .G
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Haplotype Entropy
While performing a haplotype inference, we are usu-
ally interested only in , and, hence, works as a nui-H p
sance parameter in equation (1). Here, we follow Zhang
et al. (2001) in eliminating the nuisance parameter by a
maximization procedure—that is, we replace in equa-p
tion (1) with its maximum likelihood estimate (MLE).
Thus, we have the following profile log likelihood:
k0 s sk kl(GFH)p log ,
2n 2nkp1
where denotes the number of different haplotypes ink0
, and denote their respective frequencies. WeH s , … ,s1 k0
define , where is the entropy of theS(H)p l(GFH) S(H)
frequencies of different haplotypes in , andH s(G)p
. Note that at-min {S(H):H is compatible with G} S(H)
tains its minimum at , the MLE of H in equation (1),ˆH
so that
ˆs(G)p S(H) . (2)
For example, suppose that
T T T TGp {(0,0,0) ,(1,0,0) ,(2,2,0) ,(1,1,2) } .
Then, there are two possible ways to decompose these
genotypes into haplotypes—namely,
H p {h /h , h /h , h /h , h /h }1 1 1 5 5 5 3 7 8
and
H p {h /h , h /h , h /h , h /h } ,2 1 1 5 5 7 1 7 8
where , , ,T T Th p (0,0,0) h p (0,1,0) h p (1,0,0)1 3 5
, and . The correspondingT Th p (1,1,0) h p (1,1,1)7 8
values of the haplotype likelihood shown in equation
(1) are
2 2p(h ) p(h ) p(h )p(h )p(h )p(h ) (3)1 5 5 3 7 8
and
2 2p(h ) p(h ) p(h )p(h )p(h )p(h ) , (4)1 5 7 1 7 8
where the unknown population frequencies of the five
different haplotypes in equation (3) satisfy the equation
p(h ) p(h ) p(h ) p(h ) p(h )p 1 . (5)1 5 3 7 8
and the unknown population frequencies of the four
different haplotypes in equation (4) are constrained by
p(h ) p(h ) p(h ) p(h )p 1 . (6)1 5 7 8
Given , and under the constraint of equation (5), theH1
maximum of the logarithm of the likelihood in equation
(3) is given by
2 2 3 3 3 1
log  log  log pS(H ) .1( ) ( ) ( )8 8 8 8 8 8
Analogously, given and under the constraint of equa-H2
tion (6), the maximum of the logarithm of the likelihood
in equation (3) is equal to
3 3 2 2 2 2 1 1
log  log  log  log pS(H ) .2( ) ( ) ( ) ( )8 8 8 8 8 8 8 8
Obviously, . Hence, .S(H ) ! S(H ) s(G)p S(H )2 1 2
In this article, we call the haplotype entropy ofs(G)
. The quantity measures the diversity of the un-G s(G)
derlying haplotypes compatible with , since the en-G
tropy is a well-known measure of variation for a system
in information theory (Jones 1979). The stronger the
interactions among the loci of , the less diverse theG
underlying haplotypes, and the smaller the value of
. To explain this claim intuitively, we consider onlys(G)
three diallelic loci, at which there are eight possible hap-
lotypes—namely, T Th p (0,0,0) , h p (0,0,1) , h p1 2 3
T T T T(0,1,0) , h p (0,1,1) , h p (1,0,0) , h p (1,0,1) ,4 5 6
and . Let be the pop-T Th p (1,1,0) , h p (1,1,1) p(h )7 8 i
ulation frequency of for . The populationh 1  i  8i
haplotype entropy, defined as is8 p(h ) log [p(h )] ,i iip1
a measure of the diversity of the above haplotype pop-
ulation. In practice, we might have only a sample of
genotypes of size n—say, —which are assumed to beG
generated from these haplotypes according to the Hardy-
Weinberg equilibrium. Then, the haplotype entropy
in equation (2) gives rise to an empirical versionˆS(H)
of the above population entropy. To see how the haplo-
type entropy changes as the strength of interaction
(i.e., dependence) increases, we first calculate this en-
tropy when there are no interactions among the three
loci. In this situation, the above eight haplotypes have
the equal probability of occurrence in individuals.1/8
As a result, the haplotype population reaches the highest
diversity as the population entropy attains the maximum
value of (Jones 1979, chapter 2). Now, we considerlog 8
the situation in which there exist some dependences
among the three loci. Note that these dependences are
apparent as increased frequencies of specific haplotypes
compared with what would be expected if alleles at the
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three loci are combined at random. For example, if we
set and ,p(h )p 1/2, p(h )p 1/2, p(h )p 0, i( 1,51 5 i
then the three loci are fully determined by the first locus.
With the entropy being equal to , the resulting hap-log 2
lotype population yields a smaller diversity than the pre-
vious one. We observe that, as an empirical version of
the population entropy, is close to its populationˆS(H)
value when n is large. Therefore, in general, the popu-
lation haplotype entropy—and, thus, its empirical ver-
sion, —tends to decrease as the strength of theseˆS(H)
dependences increases.
Testing for Interaction between Two Haplotype Blocks
Let be partitioned into two blocks—TGp (G , … ,G )1 n
say,
T
(1) (1)G G(1) (2) 1 nGp (G ,G )p , … , .(2) (2)( ) ( )[ ]G G1 n
Suppose that we are interested in testing whether there
exists interaction between the two blocks and .(1) (2)G G
This problem can be stated as testing the hypotheses that
the two blocks are independent (i.e., the null hypothesis)
versus the hypothesis that the two blocks are dependent
(i.e., the alternative hypothesis). As pointed out in the
“Haplotype Entropy” subsection, if the null hypothesis
is true, will tend to have a large value; otherwise,s(G)
it will tend to be small. Hence, can be used as as(G)
test statistic for this test. Because the distribution of
under the null hypothesis is unknown, the followings(G)
procedure is designed to calculate the P values of the
test:
Step 1: Generate random permutations of′ (2)n (G , … ,1
, and denote them by ,(2) (2) (2)G ) (G , … ,G ) jpn j,1 j,n
.′1, … ,n
Step 2: Form a random sample , , where∗ ′G jp 1, … ,nj
is formed by pairing with∗ (1) (1)G (G , … ,G )j 1 n
.(2) (2)(G , … ,G )j,1 j,n
Step 3: Calculate the haplotype entropy for each .∗Gj
An empirical P value can then be defined by the
proportion of values of that are  ;∗s(G ) s(G)j
that is, .∗ ∗ ′#{s(G ):s(G )  s(G)}/nj j
The number is usually set to a moderate number. For′n
example, it is 500 and 1,000 in this study.




can also be defined for the test, where A and V are the
sample mean and variance, respectively, of the values of
. The empirical P value calculated in step 3 can be∗s(G )j
used to examine whether the between-block interaction
existing in was obtained by chance, whereas the em-G
pirical Z score statistic more sensitively measures the
length of the distance between the genotypes under in-
vestigation and the population of genotypes without
block interactions.
The above procedure will be used below to test the
significance of the pairwise interactions among haplo-
type blocks or loci. In each case, the significance of an
interaction will be decided by a threshold for P values.
Assessment of the overall significance, to account for
multiple testing, is not straightforward, because there
are many correlations among the tests. An alternative
approach is to control the false discovery rate (FDR),
which is defined by the expected proportion of false
positives among those called significant: ∗ ∗ ∗E[V /R FR 1
. Here, for a given threshold, is the total number∗0] V
of false positives, and is the total number of inter-∗R
actions called significant according the threshold. We opt
for the recent proposal of Storey and Tibshirani (2003)
to estimate the FDR and calculate the q value, a measure
of statistical significance in terms of FDR, for each in-
dividual test under dependence.
Structure Annealing Algorithm
In this section, we propose a new algorithm, the so-
called “structure annealing algorithm,” to minimize
. The algorithm is proposed on the basis of the fol-S(H)
lowing observation. Let be a random par-(1) (2)Gp (G ,G )
tition of , and let be the corresponding(1) (2)G Hp (H ,H )
partition of . It is easy to see that, if is compatibleH H
with , then is compatible with . Furthermore,(1) (1)G H G
if is a good approximation of , then(1) (1)S(H ) s(G )
should be a good approximation of , pro-(1) (2)S(H ,H ) s(G)
vided that is compatible with and the number ofH G
loci in is not large. This observation motivated our(2)G
use of the following sequential way to minimize the ob-
jective function .S(H)
Suppose now that is partitioned into z blocks,G
, where comprises loci and(1) (z) (b)Gp (G , … ,G ) G kb
. It is preferable that be set to a smallz k p L kb bbp1
number—for example, for all examples in thisk  8b
article. The structure annealing algorithm consists of two
building blocks: a local updating algorithm and an ex-
trapolation algorithm. The local updating algorithm (de-
scribed in appendix A) is designed to simulate from the
distributions
(b) (b)˜ ˜Pr (H ) ∝ exp [S(H )/t ] ,b
for , where is called the “temperature” ofbp 1, … ,z tb
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this distribution, and , which is(b) (1) (b)˜H p (H , … ,H )
compatible with . The extrapolation(b) (1) (b)˜G p (G , … ,G )
algorithm (described in appendix B) is designed to ex-
trapolate to . The structure annealing algo-(b) (b1)˜ ˜H H
rithm starts with the simulation from by the(1)˜Pr (H )
local updating algorithm, where . Since the(1) (1)˜H p (H )
block size of is usually small, the iteration number(1)G
of the local updating steps is also moderate at this step.
We denote this iteration number by , and setm m p1 1
for all examples in this article. Then, the algo-10,000
rithm proceeds for steps. The th step con-z 1 (b 1)
sists of two substeps, which are described as follows.
1. Extrapolation: extrapolate the haplotype , which(b)˜H
is obtained at the last iteration of the th step, to ab
compatible haplotype pair of .(b1)˜G
2. Local updating: simulate from the distribution
by the local updating algorithm for(b1)˜Pr (H ) mb1
steps.
The is a monotone increasing function of b; formb
example, we set for andm p m # b bp 1,2, … ,z 1b 1
. Here, as in the article by Kirkpat-m p 10#m # zz 1
rick et al. (1983), we set a large iteration number for
the last step simulation.
Results
Simulated Data Sets
We used a coalescent-based program called MS, by
R. Hudson, to simulate haplotypes for the four different
situations described by quantities (v,R)p (4,0),(4,4),
, and . Here , is(4,20) (16,16) vp 4N m, Rp 4N r Ne e e
the effective population size, m is the total per-generation
mutation rate across the region sequenced, and r is the
length, in morgans, of the region sequenced.
For each setting of , this generated 40 indepen-(v,R)
dent data sets, each containing 40 haplotypes. For each
data set, the haplotypes were randomly paired to form
20 genotypes. As a result, for each case of we(v,R),
had 40 sets of 20 genotypes. They are denoted by
, with . We split eachTG , … ,G G p (G , … ,G )1 40 i i,1 i,20
into two parts of equal length, and , for(1) (2)G G Gi,j i,j i,j
and . In total, we have 80 ge-ip 1, … ,40 jp 1, … ,20
notype segments. With these segments, 20 new data sets,
which are denoted by , are formed, where∗ ∗G , … ,G1 20
is formed by attaching the segment to the∗ (2)G Gk 20k,j
segment for . The above construction(1)G kp 1, … ,20k,j
procedure shows that there are two independent blocks
in each .∗Gk
In the following, we will regard as samples∗ ∗G , … ,G1 20
from a population in which the two genotype blocks are
independent, whereas we will regard as sam-G , … ,G1 20
ples from a population in which the two genotype blocks
are dependent. To evaluate the power of our procedure,
we applied it to these genotype data sets. The resulting
P values and Z scores are summarized in figure 1. To
find the interesting blocks, we further analyzed these P
values by setting lower and upper thresholds of .01 and
.15. We say two blocks are dependent if the correspond-
ing P value is.01, whereas we say they are independent
if the corresponding P value is .15. The performance
of our procedure is measured by the proportions of false
positives and negatives, and . That is, is the pro-F F Fa n a
portion of false rejections of the null hypothesis when
the null hypothesis is true, and is the proportion ofFn
false nonrejections of the null hypothesis when the al-
ternative is true. For the above simulated data, we have
when , and(F ,F )p (0, 2/20) (v,R)p (4,0) (F ,F )pa n a n
when , (4,20), and (16,16). These re-(0,0) (v,R)p (4,4)
sults show that our procedure is, indeed, an effective
tool for detecting haplotype interactions. As pointed out
in the Introduction, the coalescent model can capture
certain main features in a haplotype population (Ste-
phens et al. 2001). The above simulated coalescent mod-
els might share some common features with real hap-
lotype data. Thus, these thresholds were used to guide
our choice of the corresponding thresholds when we
applied our method to the Dutch type 1 diabetes data
below.
Type 1 Diabetes Data
Thirty-six candidate genes, listed in table 1, were se-
lected from pathways that are potentially implicated in
the development and progression of atherosclerosis: lipid
and homocysteine metabolism, regulation of blood pres-
sure and coagulation, inflammation, cellular adhesion,
and matrix integrity (Cheng et al. 1999; Dassen et al.
2001). They have all been reported in the Online Men-
delian Inheritance in Man (OMIM) database. Dassen et
al. (2001) described an assay, for genotyping a panel of
65 SNPs that represent variation within these genes, that
is an early version of RMS Research Assay for Cardio-
vascular Disease Genetics designed by Roche Molecular
Systems. Most of these SNPs have been shown to be
implicated with some metabolic diseases, such as car-
diovascular disease, coronary artery disease, hyperten-
sion, asthma, obesity, atherosclerosis, myocardial in-
farction, hyperlipidemia, Alzheimer disease, and others
(see table 1 and OMIM for more details). The rest of
these SNPs are either the polymorphisms at (or close to)
the promoter regions that may (directly or indirectly)
play certain dysregulation roles for the genes of interest
or the polymorphisms at coding regions with nonsynon-
ymous changes (Cheng et al. 1999; Dassen et al. 2001;
Flori et al. 2003; Vatay et al. 2003). For example, V67
was selected because it could have a protective role
against type 2 diabetes (NIDDM) (Vatay et al. 2003).
V66 was included because it often interfered with our
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Figure 1 The P values and Z scores for 40 sets of genotypes with , , and . The dotted lines are for the(v,R)p (4,0) (4,4) (4,20) (16,16)
data sets in which there are interactions between two haplotype blocks, and the lines with small triangles are for the data sets in which there
are no interactions between the two haplotype blocks.
ability to call V67 correctly. We had no prior functional
information, other than that its proximity to V67 could
mean that it would also have impact on the function of
the gene TNF. As pointed out in the Introduction, since
both diabetes mellitus and atherosclerosis can be re-
garded as metabolic diseases with many overlapping bio-
chemical and clinical parameters, the variants that are
susceptible to atherosclerosis may also be the cause of
type 1 diabetes. Therefore, this assay was also applied
to a Dutch cohort with diabetes that includes 136 un-
related individuals (89 patients with type 1 diabetes with
impaired endothelial function and 47 healthy control
individuals). Endothelial function was assessed by mea-
suring changes in forearm blood flow after pharmaco-
logical interventions. The DNA samples from the 136
individuals were genotyped by use of PCR. This led to
136 genotypes of 65 loci. Nine loci (V58, V59, V66,
V67, V5, V57, V51, V52, and V30) were not used in
the following data analysis, since these loci have the so-
called “heavy-missing” problem, where 21% of the
136 individual genotypes were incomplete in the PCR
experiments. The heavy-missing problem may introduce
the bias in our data analysis. The cutoff point of 21%
was selected on the basis of our experience. We ended
up with a 136#56 data matrix. Each genotype can be
divided into 16 blocks, according to their chromosome
identities (see table 1 for more details).
We started with the search for pairwise interactions
among these 16 unlinked blocks. The search was per-
formed on the cases and controls separately. The P values
for the cases and controls were compared by plotting
them in graphs, as shown in figures2 and 3, respectively.
Table 1
SNPs Used in the Present Study
Block and Variant (Symbol, dbSNP rs #) Gene Name (OMIM #) Location Reported Implication
1:
C677T (V36,1801133) MTHFR (MIM 607093) 1p36.3 Risk factor in vascular disease
Arg506Gln (V53, 6025) F5 (MIM 227400) 1q23 Activated protein C resistence
Ser128Arg (V61, 5361) SELE (MIM 131210) 1q23-25 Coronary artery disease
Leu554Phe (V62, 5355) SELE (MIM 131210) 1q23-25 Coronary artery disease
Met235Thr (V42, 699) AGT (MIM 106150) 1q42-43 Hypertension
Val7Met (V43, 664) NPPA (MIM 108780) 1p36.2 Hypertension
T2238C (V44, 2238) NPPA (MIM 108780) 1p36.2
2:
Thr71Ile (V8, 1367117) APOB (MIM 107730) 2p24 Increased plasma low-density
lipoprotein cholesterol level
Arg3500Gln (V9, 5742904) APOB (MIM 107730) 2p24 Hypercholesterolemia
3:
Pro12Ala (V19, 1801282) PPARG (MIM 601487) 3p25 Nonsynonymous change, type 2 diabetes
A1166C (V41, 5186) AGTR1 (MIM 106165) 3q21-25 Hypertension
4:
Gly460Trp (V45, 4961) ADD1(MIM 102680) 4p16.3 Hypertension
G455A (V58, 1800790)a FGB (MIM 134830) 4q28 Progression of atherosclerosis
5:
Arg16Gly (V49, 1042713) ADRB2 (MIM 109690) 5q32-34 Asthma
Gln27Glu (V50, 1042714) ADRB2 (MIM 109690) 5q32-34 Obesity
G873A (V59, 1062535)a ITGA2 (MIM 192974) 5q23-31 Glycoprotein Ia/IIa surface expression
6:
C93T (V4, 1652503) LPA (MIM 152200) 6q27 Atherosclerosis
Thr26Asn (V32, 1041981) LTA (MIM 153440) 6p21.3 Myocardial infarction
Thr26Asn (V68, 1041981) TNFb (MIM 153440) 6p21.3 Myocardial infarction
G376A (V64, 1800750) TNF (MIM 191160) 6p21.3 Malaria
G308A (V65, 1800629) TNF (MIM 191160) 6p21.3 Asthma
G244A (V66, 673)a TNF (MIM 191160) 6p21.3
G238A (V67, 361525)a TNF (MIM 191160) 6p21.3 Protective against type 2 diabetes
G121A (V5, 1800769)a LPA (MIM 152200) 6q27
7:
A922G (V37, 1800779) NOS3 (MIM 163729) 7q36
C690T (V38, 3918226) NOS3 (MIM 163729) 7q36
Glu298Asp (V39, 1799983) NOS3 (MIM 163729) 7q36 Hypertension, Alzheimer disease
5G(675)4G (V56, 1799768) PAI1 (MIM 173360) 7q21.3-22 Coronary artery disease
Met55Leu (V25, 3202100) PON1 (MIM 168820) 7q21.3 Cardiovascular disease
Gln192Arg (V26, 662) PON1 (MIM 168820) 7q21.3 Coronary artery disease
Ser311Cys (V27, 7493) PON2 (MIM 602447) 7q21.3 Coronary artery disease
G11053T (V57, 7242)a PAI1 (MIM 173360) 7q21.3-22
8:
Trp64Arg (V18, 4994) ADRB3 (MIM 109691) 8p12-11.2 Type 2 diabetes in some populations
T93G (V21, 1800590) LPL (MIM 238600) 8p22 Combined hyperlipidemia
Asp9Asn (V22, 1801177) LPL (MIM 238600) 8p22 Combined hyperlipidemia
Asn291Ser (V23, 268) LPL (MIM 238600) 8p22 Combined hyperlipidemia
Ser447term (V24, 328) LPL (MIM 238600) 8p22 Type 1 hyperlipidemia
9:
Thr347Ser (V6, 675) APOA4 (MIM 107690) 11q23
Gln360His (V7, 5110) APOA4 (MIM 107690) 11q23 The metabolism of apolipoprotein B
C641A (V10, 2542052) APOC3 (MIM 107720) 11q23
C482T (V11, 2854117) APOC3 (MIM 107720) 11q23 Increased plasma triglyceride levels
T455C (V12, 2854116) APOC3 (MIM 107720) 11q23 Increased plasma triglyceride levels
C1100T (V13, 4520) APOC3 (MIM 107720) 11q23 Increased plasma triglyceride levels
C3175G (V14, 5128) APOC3 (MIM 107720) 11q23 Increased plasma triglyceride levels
T3206G (V15, 4225) APOC3 (MIM 107720) 11q23
5A(1171) 6A (V51, 3025058)a MMP3 (MIM 185250) 11q23 Coronary heart disease
G20210A (V52, 1799963)a F2 (MIM 176930) 11p11-q12 Hyperprothrombinemia
(continued)
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Table 1 (continued)
Block and Variant (Symbol, dbSNP rs #) Gene Name (OMIM #) Location Reported Implication
10:
Trp493Arg (V46, 5742912) SCNN1A (MIM 600228) 12p13 Nonsynonymous change
Thr663Ala (V47, 2228576) SCNN1A (MIM 600228) 12p13 Nonsynonymous change
C825T (V48, 5443) GNB3 (MIM 139130) 12p13 Hypertension
11:
323 10-bp Ins/Del (V54, 5742910) F7 (MIM 227500) 13q34 Hypertension
Arg353Gln (V55, 6046) F7 (MIM 227500) 13q34 Myocardial infarction
12:
C480T (V20, 1800588) LIPC (MIM 151670) 15q21-23 Regulation of plasma lipids
13:
C631A (V29, 1800776) CETP (MIM 118470) 16q21
Ile405Val (V31, 5882) CETP (MIM 118470) 16q21 Plasma high-density lipoprotein
cholesterol level
Asp442Gly (V33, 2303790) CETP (MIM 118470) 16q21 Cholesteryl ester transfer protein
deficiency
G1A (V34, 5742907) CETP (MIM 118470) 16q21 Cholesteryl ester transfer protein
deficiency
C629A (V30, 1800775)a CETP (MIM 118470) 16q21
14:
Alu element Ins/Del (V40, 1799752) ACE (or DCP1) (MIM 106180) 17q23 Myocardial infarction
Leu33Pro (V60) ITGB3 (MIM 173470) 17q21.32 Coronary heart disease
15:
Cys112Arg (V16, 429358) APOE (MIM 107741) 19q13.2 Hyperlipoproteinemia
Arg158Cys (V17, 7412) APOE (MIM 107741) 19q13.2 Hyperlipoproteinemia
Gly241Arg (V63, 1799969) ICAM1 (MIM 147840) 19p13.3-13.21
NcoI/ (V28, 5742911) LDLR (MIM 606945) 19p13.2 Cholesterol homeostasis
16:
Ile278Thr (V35, 5742905) CBS (MIM 236200) 21q22.3 Homocystinaria
NOTE.—A list of references regarding the SNPs in this table can be downloaded from the Research at Brigham and Women’s Hospital
download site.
a Locus was not used in data analysis because of the problem of “heavy missing,” in the sense that at least of the 136 individual21%
genotypes are imcomplete at this locus.
We obtained 10 pairs of interacting blocks, located on
chromosome pairs (1,4), (1,12), (1,19), (2,7), (3,19),
(5,7), (6,7), (6,21), (7,11), and (17,21) (seetable 2 for
more details). These block pairs were selected by use of
the following criteria: for the up interaction, we claimed
that there was an increase in haplotype interaction if the
P value of the controls was 1.15, the P value of the cases
was .01, and the Z score of the cases was 2. This
says that, in contrast to the healthy individuals, there is
a significant interaction between two haplotype blocks
under consideration in the individuals with disease. For
the down interaction, we claimed that there was a de-
crease in haplotype interaction if the P value of the cases
was 1.15, the P value of the controls was .01, and the
Z score of the controls was 2. This implies that, in
contrast to the healthy individuals, there is no significant
interaction between two haplotype blocks under consid-
eration in the individuals with disease. Among these se-
lected blocks, the up-interaction pairs for chromosome
pairs (1,4), (1,12), (1,15), (1,19), (6,7), and (17,21) in-
dicate that the pathways harboring these variants may
have been modified by adding some interactions between
some genes in the individuals who had the disease. Anal-
ogously, the down-interaction pairs on chromosome
pairs (3,19), (2,7), (6,21), (7,11), (5,7), (12,15) indicate
that the related pathways may have been changed, since
interactions between some genes are disrupted. Note
that, with the P value thresholds .01 and .15 for cases
and controls, respectively, the corresponding estimated
FDRs of these multiple tests for cases and controls are
0.017 and 0.029. There will be more interaction pairs
if we take .035 and .2 as the thresholds for cases and
controls, respectively. The FDRs will then become 0.040
and 0.048 (see table 2 for more details).
To see how these interactions modify the related path-
ways, we ran our procedure on the pairs of variants on
these blocks. Consequently, 25 pairs of variants were
found to show certain evidence of susceptibility to the
disease. Table 2 indicates that these variants are dis-
tributed on 19 genes: NPPA, SELE, ADOB, AGTR1,
ADRB2, LPA, TNF, TNFb, DCP1, ADD1, SCNN1A,
APOE, NOS3, LPL, LIPC, PON1, CBS, APOA4, and
APOC3. Note that APOB, ADRB2, LPA, APOE, LPL,
LIPC, PON1, and APOA4 are on the pathway of lipid
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Figure 2 The P values of testing the interactions of blocks 1–8 with the other blocks, for the cases and controls in the Dutch type 1
diabetes data. The dotted lines are for the cases, and the lines with small triangles are for the controls. The normal line, a contrast between
the two lines, is derived by subtracting the corresponding P values of the control from those of the case.
metabolism; CBS is on the pathway of homocysteine
metabolism; NPPA, AGTR1, ADRB2, DCP1, SCNN1A,
and NOS3 are on the pathway of blood pressure; SELE
is on the pathway of coagulation; SELE, TNF, and TNFb
are on the pathway of inflammation; and ADD1 is on
the pathway of matrix integrity. Thus, within the path-
way of lipid metabolism there are seven up or down
interactions, denoted by the symbols () and () re-
spectively, among some genes. They are V9:V22 (APOB:
LPL) (), V8:V20 (APOB:LIPC) (), V4:V26 (LPA:
PON1) (), V26:V7 (PON1:APOA4) (), V25:V10
(PON1:APOC3) (), and V25:V12 (PON1:APOC3)
(). These interactions are predisposing to the disease.
Similarly, within the pathway of blood pressure, there
is one down interaction: V50:V38 (ADRB2:NOS3) ().
The rest are related to interactions among the six path-
ways mentioned above. Here, up interaction (down in-
teraction) is trying to describe the biological phenome-
non through which the pathways of lipid metabolism,
homocysteine metabolism, blood pressure, inflamma-
tion, and matrix integrity are modified, by creating (dis-
rupting) interactions among some genes that lie in these
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Figure 3 The P values of testing the interactions of blocks 9–16 with the other blocks, for the cases and controls in the Dutch type 1
diabetes data. The dotted lines are for the cases, and the lines with small triangles are for the controls. The normal line, a contrast between
the two lines, is derived by subtracting the corresponding P values of the control from those of the case.
pathways. Similar to what Sudbery (1998, p. 144) has
suggested, the up interactions would suggest that those
interactions lead to a susceptibility to the disease,
whereas the down interactions could imply that the re-
lated interactions may have a protective effect on de-
veloping the disease. These results indicate a complicated
feature of (possibly nonmultiplicative) effects of the in-
teractions on the risk for type 1 diabetes.
Note that Dassen et al. (2001) have identified a set of
dominant variants—V4, V15, V28, and V50—that are
on chromosomes 6, 11, 19, and 5, respectively. This,
combined with the above results, yields the following
transitive and disease-predisposing variants, in the sense
that there are significant increases (or decreases) of in-
teractions of these variants with some dominant vari-
ants: V26, V37, V38, V39, V7, V8, V10, V11, V12,
V13, V65, V68, V20, V25, and V47.
In the next step, we screened for interactions in linked
regions. For simplicity, we adopted the following strat-
egy. Taking block 1 as example, we sequentially tested
six subblock pairs for the cases and controls: the first
pair was , with 1 being the splitting lo-{1},{2,3,4,5,7}
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Table 2
Haplotype Interactions that Predispose to Type 1 Diabetes
BLOCK PAIR/CHROMOSOMAL LOCATION
OR VARIANT PAIR/GENE PAIRa
CASES CONTROLS
P Value q Value Z Score P Value q Value Z Score
(1,4)/(1,4) .000 .000 2.9732 .40 .13 .133
(V44:V45)/(NPPA:ADD1) .01 3.4988 .964 1.0808
(1,10)/(1,12) .000 .000 3.5908 .22 .1 .712
(V62:V46)/(SELE:SCNN1A) .032 5.8305 1.00 .3251
(1,15)/(1,19) .000 .000 3.7758 .60 .18 .243
(V43:V17)/(NPPA:APOE) .018 3.2417 .93 .3975
(2,7)/(2,7) .31 .12 .4364 .01 .019 2.4063
(V8:V39)/(APOB:NOS3) .35 .2049 .002 3.7312
(2,8)/(2,8) .03 .036 2.0210 .20 .10 .709
(V9:V22)/(APOB:LPL) .002 2.3361 1.00 .9950
(2,12)/(2,15) .032 .037 2.2290 .59 .18 .315
(V8:V20)/(APOB:LIPC) .6 .4021 .022 2.2037
(3,15)/(3,19) .258 .11 .6140 .00 .000 4.380
(V41:V16)/(AGTR1:APOE) .528 .1457 .0475 2.1793
(5,7)/(5,7) .22 .10 .9170 .000 .000 2.2606
(V50:V38)/(ADRB2:NOS3) .37 .3814 .01 2.7346
(6,7)/(6,7) .01 .017 2.4328 .30 .12 .6584
(V4:V26)/(LPA:PON1) .0075 3.1221 .996 1.3345
(V4:V37)/(LPA:NOS3) .016 3.0343 .968 .7989
(V4:V39)/(LPA:NOS3) .636 .5031 .046 2.6121
(V65:V38)/(TNF:NOS3) .014 2.5465 .85 1.0279
(V68:V37)/(TNFb:NOS3) .01 3.6194 .222 .6165
(6,16)/(6,21) .45 .15 .4934 .000 .000 2.0156
(V32:V35)/(TNFb:CBS) .61 .2664 .0375 4.2425
(7,9)/(7,11) .21 .10 .9432 .000 .000 2.9033
(V38:V7)/(NOS3:APOA4) .16 1.6673 .000 11.3963
(V26:V7)/(PON1:APOA4) .37 .3737 .025 2.3077
(V25:V10)/(PON1:APOC3) .51 .0683 .028 2.4287
(V25:V12)/(PON1:APOC3) .78 .8031 .028 2.1233
(V38:V11)/(NOS3:APOC3) .786 .6522 .004 3.5639
(V37:V11)/(NOS3:APOC3) .78 .6673 .028 2.6518
(V37:V10)/(NOS3:APOC3) .296 .4199 .002 4.8354
(V37:V12)/(NOS3:APOC3) .73 .7839 .000 4.7122
(V38:V13)/(NOS3:APOC3) .71 .4653 .024 3.3368
(9,13)/(11,16) .02 .027 2.3164 .19 .1 .7887
(10,12)/(12,15) .155 .09 .9611 .01 .019 2.5475
(V47:V20)/(SCNN1A:LIPC) .172 1.1070 .002 4.7115
(14,16)/(17,21) .000 .000 4.1709 .59 .18 .1466
(V40:V45)/(DCP1:CBS) .025 4.0039 .697 .7439
a Block pairs/chromosomal locations are given in the format “(1,4)/(1,4),” and variant pairs/gene pairs are given in the
format “(V44:V45)/(NPPA:ADD1).”
cation; the second pair was , with 2 being{1,2},{3,4,5,7}
the splitting location; and so on. Here, the numbers 1,
2, 3, 4, 5, 6, and 7 denote the seven variants in block
1. The six subblock pairs are uniquely defined by six
splitting locations: 1, 2, 3, 4, 5, and 6. We compared
the resulting six pairs of P values and Z scores in table
3. It suggests that there exists some disease-predispos-
ing interaction between subblock pairs and{1,2,3,4}
. Following the same argument as above, for{5,6,7}
block 6 we may conclude that variant V64 might be a
transitive disease-predisposing variant, because the dom-
inant variant, V4, is at subblock . The evidence{1,2,3}
of disease-predisposing interactions within the other
blocks is reported in table 4, which yields the transitive
variant V14. Note that, in practice, we need to test the
interactions for all bipartitions of seven loci, since the
strength of linkage disequilibrium patterns is not, typi-
cally, a monotonic function of genetic distance. Our pro-
cedure can be easily extended to this general setting,
since it does not use any information on genetic distances
among these loci.
Discussion
The logistic regression mentioned in the Introduction is
a very important genotype-based tool for detecting dom-
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Table 3





P Value Z Score P Value Z Score
1 .42 .0497 .23 .6620
2 .06 1.5060 .40 .3271
3 .07 1.6728 .69 .5059
4 .00 2.4910 .31 .4083
5 .05 1.6461 .53 .0784
6 .10 1.2424 .33 .2145
Table 4







P Value Z Score P Value Z Score
1:
4 .00 2.4910 .31 .4083
5 .05 1.6461 .53 .0784
6:
3 .27 .5888 .00 4.2116
7:
5 .04 1.9404 .26 .5867
8:
1 .16 .7903 .01 2.9411
2 .52 .2147 .02 3.0241
9:
3 .11 1.3035 .00 7.8697
4 .10 1.1386 .00 9.2839
5 .13 .8928 .00 3.6252
6 .19 .8848 .00 4.8922
7 .46 .1373 .02 1.7784
inant polymorphisms and epistatic effects (i.e., genotype
interactions) that are associated with disease. One dis-
advantage of this method over some haplotype-based
methods is that it ignores the potential disease-predis-
posing haplotype interactions. To contend with this dis-
advantage, we have presented a procedure for evaluating
the contributions of these haplotype interactions to sus-
ceptibility to disease, in which the entropy is used to
measure the diversity of a haplotype population. Our
procedure can be easily generalized to other measures
of the haplotype diversity (Weir 1996; Clayton 2002).
Of course, for applications, we should combine these
two methods, in order to extract more complete infor-
mation from unphased genotype data, in the following
steps: first, apply the logistic regression to detect dom-
inant disease-predisposing variants and genotype inter-
actions; then, as a complement, use our procedure to
find potential haplotype interactions; finally, predict the
transitive variants by finding the variants that are inter-
acting with the dominant ones.
In the first step, we assume a sample of cases andn1
controls, each of whom is genotyped at m polymor-n2
phisms. Let be the probability of individual j being apj
case rather than a control. Following McCullagh and
Nelder (1989), we model aspj
pjlogit(p)p log p b  b x … b x ,( )j 0 1 1 m m1 pj
where are covariates depending on the ge-x , … ,x1 m
notypes of the individual, and are coefficientsb , … ,b0 m
to be estimated. To examine the effects of a set of poly-
morphisms, we can test whether the data are signifi-
cantly better represented when these polymorphisms are
included in the model compared with when they are not
in the model, through use of likelihood-ratio tests (Cor-
dell and Clayton 2002). This is equivalent to testing
whether the corresponding coefficients are significantly
different from 0. Similarly, we can account for the ge-
notype interactions by adding some epistatic terms to
the above model. A commonly used strategy for eval-
uation of the effects of the different polymorphisms is
to fit these models in a stepwise fashion. Following Cor-
dell and Clayton (2002), for the Dutch type 1 diabetes
data, we first code , 0.5, and 0.5 for geno-x p 0.5j
types 0, 2, and 1, respectively, and we also code 0.5 for
the cases in which genotypes are missing. We set .05 as
a nominal significance level for all these tests involved
in the stepwise logistic-regression procedure. This yields
seven dominant disease-susceptibility alleles on chro-
mosomes 3, 6, 7, 6, 11, 19, and 2, respectively:
V41(AA), V4(TT), V26(GG), V64(GG), V15(GG),
V28(), V9(missing), and one genotype interaction be-
tween V41(AA) and V64(GG), where, for example, in
the notation “V41(AA),” V41 is the name of the variant
and (AA) is one of its alleles (see table 5). The result is
slightly different from the prediction-based logistic-re-
gression procedure of Dassen et al. (2001); this might
be because of different criteria being used.
In the second step, we start with a search for the
haplotype interaction between blocks located on dif-
ferent chromosomes, followed by testing of the inter-
actions within each block. If two blocks are found in-
teracting, we can further narrow the search area to
identify which variants in the blocks are involved in this
interaction. For the Dutch type 1 diabetes data, in the
“Results” section we have shown nine pairs of inter-
acting blocks that are predisposed to type 1 diabetes.
Combining with the result from the first step, we can
infer some transitive disease-predisposing variants, as
shown in the “Results” section. The results demonstrate
a complicated gene-gene interaction network, which
might predispose to type 1 diabetes through modifying
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Table 5




Intercept .93277 .42811 175.35
V41 .04511 1.10738 170.65 .0302
V4 17.2308 1.10738 162.98 .0056
V26 1.3954 .94438 158.65 .0375
V64 .73047 1.21786 151.01 .0057
V15 4.58316 1.49003 141.54 .0021
V9(missing) 19.6659 73.3194 137.1299 .0357
V28 4.8015 1.9924 129.9424 .0073
V41:V64 11.0055 4.3711 122.5526 .0066
a Variants added sequentially.
the pathways of lipid metabolism, blood pressure, in-
flammation, coagulation, and matrix integrity.
Use of interaction between unlinked genomic regions
has been suggested for improving power to detect loci
of small effect on the disease phenotype; for example,
in type 1 diabetes (Cordell et al. 1995, 2000; Bugawan
et al. 2003), type 2 diabetes (Cox et al. 1999), and
inflammatory bowel disease (Cho et al. 1998). Cordell
et al. (1995) reported that there are interactions between
the loci IDDM1 (chromosome 6p21) and IDDM2
(chromosome 11p15) and between the loci IDDM1 and
IDDM4 (on chromosome 11q13.3), in the context of
the logistic regression model. Cox et al. (1999) showed
that the loci on chromosomes 2 and 15 interact to in-
crease susceptibility to type 2 diabetes, in the context
of a nonparametric LOD score. Cox et al. (2001) per-
formed a systematic screen for correlation between fam-
ily-specific nonparametric LOD scores to evaluate evi-
dence of interactions between some unlinked regions on
chromosomes 1, 2, 3, 4, 6, 11, and 19. These methods
are usually restricted to family data. Unlike these au-
thors, we focus here on interactions between genetic
variants in a list of potential candidate genes across a
number of chromosomes, where some of these variants
have already been shown to be associated with some
metabolic diseases. Moreover, the proposed approach
is specified for unphased genotype data (possibly with
missing problems) from case-control studies. Thus, our
method could be a valuable contribution to a genome-
wide association study of a complex disease, especially
when direct determination of the molecular haplotypes
from experiment or family data is not feasible.
Although significant and consistent linkage evidence
was reported for the susceptibility intervals IDDM8 (on
chromosome 6q27), IDDM4 (on 11q), and IDDM5 (on
6q25), evidence for most other intervals varies in dif-
ferent data sets, probably because of a weak effect of
the disease genes, genetic heterogeneity, random vari-
ation, or inappropriate correction for multiple tests (see
Pugliese 2001). To reduce the possible effect of genetic
heterogeneity, we need to confirm our initial finding by
analyzing other populations in future studies. Since we
compared correlated variants, it is important to take
into account the potential effects of multiple tests on
the power of our procedure. For our case, there are 120
pairwise tests among 16 haplotype blocks. A simple
Bonferroni (or Dunn-Sidak) correction leads to the ad-
justed threshold of for P values if we want44.17# 10
to achieve the significance level of .05; there are only
seven block pairs in table 2 that remained nominally
significant after this correction. Such a correction seems
too conservative, because of high dependences among
these tests. This has been confirmed by Bugawan et al.
(2003) on the basis of a permutation procedure. Un-
fortunately, using resampling methods such as permu-
tation can be computationally prohibitive in our case.
However, we have shown that the recently developed
procedure of Storey and Tibshirani (2003) is applicable
to our setting.
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The local updating algorithm includes two operators, n-mutation and peer learning. In every iteration, they are
selected to perform with probability 0.2 and 0.8, respectively. Of course, the probabilities can be tuned by the user,
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but a large performing probability is usually assigned to the peer learning operator, since it tends to force the
haplotypes to coalesce. The two operators are described below.
n-Mutation Operator
In the n-mutation operator, a total of haplotype pairs at the heterozygous ( ) or missingmax {1,g n} g p 2b ij
( ) loci are randomly selected to undergo changes, where is the total number of heterozygous andg p 9,8,7 gij b
missing loci in , and n is the mutation rate specified by the user. The n is usually set to a small number; for˜Gb
example, we set for all examples in this article. The changes are accepted or rejected according to thenp 0.001
Metropolis-Hastings rule (Metropolis et al. 1953; Hastings 1970)—that is, the new haplotypes are accepted(b)˜H∗
with probability , wheremin (1,r )m
(b) (b) (b) (b)˜ ˜ ˜ ˜[s(H ) s(H )] T(H r H )∗ ∗r p exp ,m (b) (b)˜ ˜{ }t T(H r H )b ∗
where denotes the transition probability between the current and new haplotypes. The transition proceedsT(7 r 7)
as follows. If the pair is selected to undergo a change and if , then the values of and(h ,h ) g p 2 hb,ij,1 b,ij,2 ij b,ij,1
will be simply swapped by setting and . If , one of the pairs ,h h p 1 h h p 1 h g p 9 (0,0)b,ij,2 b,ij,1 b,ij,1 b,ij,2 b,ij,2 ij
, , and are equally likely to be reassigned to . Similarly, if or 7, one of the possible(0,1) (1,0) (1,1) (h ,h ) g p 8b,ij,1 b,ij,2 ij
haplotype pairs is also equally likely to be reassigned to . The other selected haplotype pairs will be(h ,h )b,ij,1 b,ij,2
mutated in the same way, but independently. It is easy to see that the transition is symmetric, in the sense that
.(b) (b) (b) (b)˜ ˜ ˜ ˜T(H r H )p T(H r H )∗ ∗
Peer Learning Operator
The peer learning operator works as follows.
1. Randomly select one haplotype—say, —from the set .h {h ,h ; … ; h ,h }b,u, b,1,1 b,1,2 b,n,1 b,n,2v
2. Randomly select one haplotype—say, —from the sethb,s,t
{h ,h ; … ; h ,h ; h ,h ; … ; h ,h }b,1,1 b,1,2 b,u1,1 b,u1,2 b,u1,1 b,u1,2 b,n,1 b,n,2
with probability , where , is the number of different2w /  w w p exp {d(h ,h )/t } d(h ,h )b,s,t b,i,j b,i,j b,u, b,i,j sel b,u, b,i,jv vi(u jp1
haplotypes at the first loci of and , and is the so-called “selection temperature.”b k h h ti b,u, b,i,j selvip1
3. For each genotype , if or 1, we keep unchanged; if , 9, 8, or 7 and , weg g p 0 h g p 2 h p huj uj b,uj, uj b,uj, b,sj,tv v
keep unchanged with probability and change to with probability ; if , 9, 8, or 7h p h h 1 p g p 2b,uj, l b,uj, b,sj,t l ujv v
and , we keep unchanged with probability and change to with probability .h ( h h 1 p h h pb,uj,( ) b,sj,t b,uj, l b,uj, b,sj,t lv v v
We update the complementary pair of accordingly, such that they are compatible with .h gb,u, uv
4. According to the Metropolis-Hastings rule, accept the new haplotype pair with probability , wheremin {1,r}l
(b) (b) (b) (b)˜ ˜ ˜ ˜[s(H  s(H )] T(H r H )∗ ∗r p exp .l (b) (b)˜ ˜{ }t T(H r H )b ∗
Here, the transition probability equals
a31(b) (b) a a˜ ˜ 1 2T H r H p p (1 p ) ,( ) ( )∗ l l 2
where is the total number of the common haplotypes of and at the heterozygous and missing loci,(b) (b)˜ ˜a H H a1 ∗ 2
is the total number of the different haplotypes of and at the heterozygous and missing loci, and counts(b) (b)˜ ˜H H a∗ 3
the total number of times that the haplotype values in the complementary haplotype pair of are randomlyhb,u,v
assigned. The is a user-specified parameter. We set for all examples in this article. The transitionp p p 0.9l l
probability can be computed similarly.(b) (b)˜ ˜T(H r H )∗
This operator makes it possible for haplotypes to coalesce together very fast if it is feasible.
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Appendix B
Extrapolation
The extrapolation operator extrapolates to(b)˜H
by attaching the haplotype pairs compatible with(b1)˜H
. We call a haplotype “original” if it first appears(b1)G
in in some scanning order—for instance, the natural(b)˜H
order used in this article,(h ,h ; … ; h ,h )b,1,1 b,1,2 b,n,1 b,n,2
where is the haplotype pair of the ith geno-(h ,h )b,i,1 b,i,2
type in ; otherwise, we call it “duplicate.” The ex-(b)˜G
trapolation proceeds, in the prefixed scanning order, as
follows. If a haplotype and its complementary pair are
both “original,” it is extrapolated independently—that
is, if is a heterozygous or missing allele, thengij
is equally likely to be set to one of the(h ,h )b1,ij,1 b1,ij,2
possible haplotype pairs. If a haplotype is “duplicate,”
then it will be extrapolated according to the correspond-
ing original copy. Note that, in this case, the extrapo-
lation for the corresponding original copy has been fin-
ished. For example, if is a duplicate of , and ifh hb,u, b,s,tv
is a heterozygous or missing allele, then willg huj b1,uj,v
be set to the same value as with probabilityh pb1,sj,t e
and will be set to a value that differs from withhb1,sj,t
probability . The complementary pair of1 p he b1,uj,v
will be set accordingly, such that the pair is compatible
with . We usually set to a large value—say, 0.95—g pu e
for all examples in this article. Obviously, the extrapo-
lation operator will provide a good starting point for
the simulation from the distribution .(b1)˜P(H )
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